Goldman Sachs
BIOT

Goldman Sachs’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Goldman Sachs’s Portfolio BIOT Stock Details BIOT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$2.3M Sell
2022
Q1 		$2.3M Hold
2021
Q4 		$2.29M Sell
2021
Q3 		$2.28M Sell
2021
Q2 		$2.27M Buy
2021
Q1 		$584K Buy